Samantha L. Shterengarts

Array ( [id] => 6501577 [patent_doc_number] => 20100286292 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'PROCESS FOR THE PRODUCTION OF SUBSTITUTE NATURAL GAS' [patent_app_type] => utility [patent_app_number] => 12/763785 [patent_app_country] => US [patent_app_date] => 2010-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5322 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20100286292.pdf [firstpage_image] =>[orig_patent_app_number] => 12763785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9703483 [patent_doc_number] => 08828544 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-09 [patent_title] => 'Process and apparatus for depositing nanostructured material onto a substrate material' [patent_app_type] => utility [patent_app_number] => 13/264718 [patent_app_country] => US [patent_app_date] => 2010-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 13 [patent_no_of_words] => 4792 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13264718 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8909467 [patent_doc_number] => 08481531 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-09 [patent_title] => 'Bicyclic heterocyclyl derivatives as FGFR kinase inhibitors for therapeutic use' [patent_app_type] => utility [patent_app_number] => 13/264593 [patent_app_country] => US [patent_app_date] => 2010-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49352 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13264593 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6236370 [patent_doc_number] => 20100267668 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => '4-AZETIDINYL-1-HETEROATOM LINKED-CYCLOHEXANE ANTAGONISTS OF CCR2' [patent_app_type] => utility [patent_app_number] => 12/760855 [patent_app_country] => US [patent_app_date] => 2010-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28192 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20100267668.pdf [firstpage_image] =>[orig_patent_app_number] => 12760855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8846219 [patent_doc_number] => 08455399 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-04 [patent_title] => 'N-(4-perfluoroalkyl-phenyl)-4-triazolyl-benzamides as insecticides' [patent_app_type] => utility [patent_app_number] => 13/318946 [patent_app_country] => US [patent_app_date] => 2010-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11102 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13318946 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6493853 [patent_doc_number] => 20100200847 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE USING ANTHRACENE DERIVATIVE' [patent_app_type] => utility [patent_app_number] => 12/760076 [patent_app_country] => US [patent_app_date] => 2010-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 72 [patent_figures_cnt] => 72 [patent_no_of_words] => 27996 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20100200847.pdf [firstpage_image] =>[orig_patent_app_number] => 12760076 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6236701 [patent_doc_number] => 20100267762 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'NOVEL P2X7R ANTAGONISTS AND THEIR USE' [patent_app_type] => utility [patent_app_number] => 12/758557 [patent_app_country] => US [patent_app_date] => 2010-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 15351 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20100267762.pdf [firstpage_image] =>[orig_patent_app_number] => 12758557 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6517499 [patent_doc_number] => 20100261712 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-14 [patent_title] => 'HEMATOPOIETIC NEOPLASM CHEMOTHERAPY' [patent_app_type] => utility [patent_app_number] => 12/756213 [patent_app_country] => US [patent_app_date] => 2010-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11108 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20100261712.pdf [firstpage_image] =>[orig_patent_app_number] => 12756213 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6329780 [patent_doc_number] => 20100197933 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'Process for the Preparation of Candesartan Cilexetil' [patent_app_type] => utility [patent_app_number] => 12/755606 [patent_app_country] => US [patent_app_date] => 2010-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3840 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20100197933.pdf [firstpage_image] =>[orig_patent_app_number] => 12755606 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8909461 [patent_doc_number] => 08481525 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-09 [patent_title] => 'Kinase inhibitors and method of treating cancer with same' [patent_app_type] => utility [patent_app_number] => 13/262888 [patent_app_country] => US [patent_app_date] => 2010-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 123719 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13262888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7744469 [patent_doc_number] => 20120022069 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'ACRYLAMIDE COMPOUNDS AND THE USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/260185 [patent_app_country] => US [patent_app_date] => 2010-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37410 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20120022069.pdf [firstpage_image] =>[orig_patent_app_number] => 13260185 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6350573 [patent_doc_number] => 20100249129 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS' [patent_app_type] => utility [patent_app_number] => 12/732421 [patent_app_country] => US [patent_app_date] => 2010-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 65367 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20100249129.pdf [firstpage_image] =>[orig_patent_app_number] => 12732421 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8968693 [patent_doc_number] => 08507503 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-13 [patent_title] => 'Thienopyrimidinedione derivatives as TRPA1 modulators' [patent_app_type] => utility [patent_app_number] => 12/936451 [patent_app_country] => US [patent_app_date] => 2010-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25435 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12936451 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7550713 [patent_doc_number] => 08063046 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-22 [patent_title] => 'Benzamide derivative' [patent_app_type] => utility [patent_app_number] => 12/730093 [patent_app_country] => US [patent_app_date] => 2010-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 45038 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/063/08063046.pdf [firstpage_image] =>[orig_patent_app_number] => 12730093 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6616742 [patent_doc_number] => 20100323999 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'Therapeutic Molecules and Methods-1' [patent_app_type] => utility [patent_app_number] => 12/728304 [patent_app_country] => US [patent_app_date] => 2010-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 31246 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0323/20100323999.pdf [firstpage_image] =>[orig_patent_app_number] => 12728304 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7683691 [patent_doc_number] => 20100240720 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-23 [patent_title] => 'ALLOSTERIC JNK INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/728093 [patent_app_country] => US [patent_app_date] => 2010-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10313 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20100240720.pdf [firstpage_image] =>[orig_patent_app_number] => 12728093 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4613315 [patent_doc_number] => 07989470 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-02 [patent_title] => '3,8-substituted 8-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors' [patent_app_type] => utility [patent_app_number] => 12/727972 [patent_app_country] => US [patent_app_date] => 2010-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7117 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/989/07989470.pdf [firstpage_image] =>[orig_patent_app_number] => 12727972 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4548321 [patent_doc_number] => 07960380 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-14 [patent_title] => 'Non-anilinic derivatives of isothiazol-3(2H)-one 1,1-dioxides as liver X receptor modulators' [patent_app_type] => utility [patent_app_number] => 12/725669 [patent_app_country] => US [patent_app_date] => 2010-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 134359 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/960/07960380.pdf [firstpage_image] =>[orig_patent_app_number] => 12725669 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6644544 [patent_doc_number] => 20100227855 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-09 [patent_title] => 'HELIX 12 DIRECTED NON-STEROIDAL ANTIANDROGENS' [patent_app_type] => utility [patent_app_number] => 12/724966 [patent_app_country] => US [patent_app_date] => 2010-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 18162 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20100227855.pdf [firstpage_image] =>[orig_patent_app_number] => 12724966 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7712339 [patent_doc_number] => 20120004421 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'Process for the preparation of pyrazole derivatives' [patent_app_type] => utility [patent_app_number] => 13/256564 [patent_app_country] => US [patent_app_date] => 2010-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4675 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13256564 [rel_patent_id] =>[rel_patent_doc_number] =>)